IAA with FDA - Using big data to compare SARS-CoV-2 infection and therapeutic efficacy between human lung on a chip and animal model testing
|
Other
|
FDA
|
NIAID
|
2020
|
|
ICCVAM Ecotoxicology Workgroup (EcoWG)
|
Committee, Advisory Group, or Work Group
|
FDA
|
|
2018
|
|
ICCVAM In Vitro to In Vivo Extrapolation Workgroup (IVIVE-WG)
|
Committee, Advisory Group, or Work Group
|
ATSDR, FDA
|
NLM
|
2017
|
|
ICCVAM Metrics Workgroup (MWG)
|
Committee, Advisory Group, or Work Group
|
FDA
|
OD
|
2019
|
|
ICCVAM Nanomaterials Workgroup (NanoWG)
|
Committee, Advisory Group, or Work Group
|
FDA, CDC
|
|
2018
|
|
ICCVAM Public Forum
|
Meeting/ Workshop
|
FDA
|
NCATS
|
2014
|
|
ICCVAM Read Across Workgroup (RAWG)
|
Committee, Advisory Group, or Work Group
|
ATSDR, FDA
|
NLM
|
2017
|
|
Identification and Validation of ctDNA Quality Control Materials
|
Resource Development
|
FDA
|
|
2019
|
|
IEEE Reporting Standards for In Vivo Neural Interface Research Working Group
|
Committee, Advisory Group, or Work Group
|
FDA
|
|
2018
|
|
Image-guided Interventional Therapeutics
|
Research Initiative
|
FDA
|
CC, NCI
|
2004
|
|
Imaging Core Unit
|
Research Initiative
|
FDA
|
NEI
|
|
|
Immune Responses to Influenza Vaccination
|
Research Initiative
|
FDA
|
NIAID
|
|
|
Immunology Interest Group
|
Meeting/ Workshop
|
FDA
|
NIDDK, NHLBI, NIAID, NINDS, NIEHS, CC, NIAMS, NEI, NIDCR, NICHD, NIAAA, NIMH, NHGRI, NCCIH, NIA, NIDA, NIDCD, NIGMS, NIMHD, OD/ OIR
|
1990
|
|
Impact of Opioid-Related Emergencies on First Responders
|
Research Initiative
|
FDA
|
CC
|
|
|
Improving Genomics/Omics Technical Standards and Molecular Tools for Prebiotic Probiotic Research and Development Working Group
|
Research Initiative
|
CDC, FDA, OS
|
NCCIH, NCI, NHGRI, NIDA, NLM
|
2016
|
|
Improving Steps in the Development and Assessment of Live Microbiome-Based Products: Fecal Microbiota for Transplantation (FMT) and Live Biotherapeutic Products (LBPs)
|
Other
|
FDA
|
NIAID
|
2019
|
|
In Silico Screening for Cancer Targets
|
Research Initiative
|
FDA
|
NCI
|
|
|
In Vitro Assessment of Dermal Hypersensitivity: Using Alternative Methods to Predict Skin Sensitization
|
Research Initiative
|
FDA
|
NIEHS
|
2018
|
|
In Vitro Assessment of Respiratory Hypersensitivity: Using Alternative Methods to Predict Respiratory Sensitization
|
Research Initiative
|
FDA
|
NIEHS
|
2022
|
|
Influenza Diagnostics Risk Management Meeting (FRMM) Strategy Working Group
|
Committee, Advisory Group, or Work Group
|
CDC, FDA, ASPR
|
NIAID
|
2018
|
|
Influenza Risk Management Meeting
|
Committee, Advisory Group, or Work Group
|
CDC, FDA, OS
|
NIAID
|
2007
|
|
Influenza Viral Pathogenesis
|
Research Initiative
|
FDA
|
NIAID
|
|
|
Inhibition Of Renal Injury
|
Research Initiative
|
FDA
|
NIDDK
|
|
|
Innovation Equity Forum Steering Committee (IEF SteerCo)
|
Research Initiative
|
FDA
|
OD, NICHD, NHLBI, NINDS, NIGMS, FIC, NCATS, NIA, NCCIH
|
2022
|
|
Integrated Research Facility at Fort Detrick
|
Research Initiative
|
FDA
|
NIAID
|
|
|
Inter-Agency Working Group on the National Healthcare Quality and Disparities Report
|
Committee, Advisory Group, or Work Group
|
ACF, AHRQ, CDC, CMS, HRSA, IHS, OS, ASPE, FDA
|
NCI, NHLBI, NIMHD, OD/ DPCPSI
|
2015
|
|
Interagency Agreement NTP/NIEHS and NCTR/FDA (IAA)
|
Other
|
FDA
|
|
1993
|
|
Interagency Artificial Pancreas Working Group
|
Committee, Advisory Group, or Work Group
|
FDA
|
NIBIB, NICHD, NIDDK
|
2007
|
|
Interagency Autism Coordinating Committee (IACC)
|
Committee, Advisory Group, or Work Group
|
ACF, ACL, AHRQ, CDC, CMS, FDA, HRSA, IHS, SAMHSA
|
NICHD, NIEHS, NINDS, NIDCD, OD
|
2000
|
|
InterAgency Board (IAB)
|
Committee, Advisory Group, or Work Group
|
CDC, FDA, ATSDR
|
NIEHS
|
2010
|
|
Interagency Cancer Diagnostic Devises Task Force for Near-Patient Use (CD2)
|
Committee, Advisory Group, or Work Group
|
CMS, FDA, HRSA
|
|
2019
|
|
Interagency Collaborative Animal Research Education (ICARE) Training Project
|
Training Initiative
|
CDC, FDA, ASPR
|
OD/ OER
|
2016
|
|
Interagency Collaborative to Advance Research in Epilepsy (ICARE)
|
Committee, Advisory Group, or Work Group
|
AHRQ, CDC, FDA, HRSA, OS
|
FIC, NCATS, NHGRI, NHLBI, NIA, NIAAA, NIAMS, NICHD, NIDA, NIMH, NINDS
|
2003
|
|
Interagency Committee on Disability Research (ICDR)
|
Committee, Advisory Group, or Work Group
|
ACF, ACL, AHRQ, ATSDR, CDC, CMS, FDA, HRSA, IHS, OS, Office of the Surgeon General (OSC), SAMHSA
|
NICHD, NIDCD, NIMH, NINDS
|
1988
|
|
Interagency Committee on Human Nutrition Research (ICHNR)
|
Committee, Advisory Group, or Work Group
|
CDC, FDA, HRSA, OASH, Other
|
NCI, OD/ DPCPSI/ ODS, NICHD
|
2013
|
|
Interagency Committee on Smoking and Health
|
Committee, Advisory Group, or Work Group
|
CDC, CMS, FDA, HRSA, SAMHSA
|
NCI, NIDA
|
1985
|
|
Interagency Coordinating Committee for Newborn Screening
|
Committee, Advisory Group, or Work Group
|
AHRQ, CDC, FDA, HRSA
|
NICHD
|
2008
|
|
Interagency Coordinating Committee on Human Growth Hormone and Creutzfeldt - Jakob disease
|
Committee, Advisory Group, or Work Group
|
CDC, FDA
|
NICHD, NINDS, NIDDK
|
1985
|
|
Interagency Coordinating Committee on the Validation of Alternative Toxicological Methods (ICCVAM)
|
Committee, Advisory Group, or Work Group
|
ATSDR, FDA, CDC
|
NCI, OD, NLM
|
2003
|
|
Interagency Group for Development of Lung Infection Models for P. aeruginosa and A.baumannii
|
Committee, Advisory Group, or Work Group
|
BARDA, CDC, FDA
|
NIAID
|
2018
|
|
Interagency Group on Alzheimers Disease and Related Dementias for implementation of the National Alzheimers Project Act
|
Committee, Advisory Group, or Work Group
|
AHRQ, CDC, CMS, FDA, HRSA, AoA, ASPE, ACF, IHS, OASH, SAMHSA
|
NIA
|
2011
|
|
Interagency Group on SARS-CoV-2 Evolution and Vaccine Cadence
|
Committee, Advisory Group, or Work Group
|
ACF, ACL, AHRQ, ATSDR, CDC, CMS, FDA, HRSA, HIS, SAMHSA
|
NIAID
|
|
|
Interagency Modeling and Analysis Group (IMAG)
|
Committee, Advisory Group, or Work Group
|
AHRQ, CDC, FDA, ASPR, Other
|
CSR, NCCIH, NCI, NEI, NHGRI, NHLBI, NIA, NIAAA, NIAID, NIAMS, NIBIB, NICHD, NIDA, NIDCD, NIDCR, NIDDK, NIEHS, NIGMS, NIMH, NIMHD, NINDS, NLM, OD/ DPCPSI, OD/ DPCPSI/ OBSSR, FIC
|
2003
|
|
Interagency Morphine Milligram Equivalent (MME) Workgroup
|
Committee, Advisory Group, or Work Group
|
FDA, CDC
|
NIDA
|
2022
|
|
Interagency Oncology Task Force Fellowship: Track 4
|
Training Initiative
|
FDA
|
|
2005
|
|
Interagency Pain Research Coordinating Committee (IPRCC)
|
Committee, Advisory Group, or Work Group
|
CDC, AHRQ, FDA, SAMHSA
|
NINDS
|
2011
|
|
Interagency Pain Research Coordinating Committee (IPRCC)
|
Committee, Advisory Group, or Work Group
|
AHRQ, CDC, FDA
|
NCCIH, NIDA, NIDCR, NINDS, NINR
|
2011
|
|
Interagency Policy Council on Nutrition (IPC)
|
Committee, Advisory Group, or Work Group
|
FDA, CMS, IOS, OASH, ACL, AHRQ, ASFR, ASPE, ASPR, CDC, HRSA, IHS, NIH, OS, SAMHSA
|
NCI, NHLBI, NICHD, NIDDK
|
2021
|
|
Interagency Task Force on Trauma-Informed Care
|
Committee, Advisory Group, or Work Group
|
ACF, AHRQ, CDC, FDA, HRSA, IHS, OS, SAMHSA
|
NICHD
|
2018
|
|
Interagency Workgroup on Technology to Facilitate Aging in Place
|
Research Initiative
|
ACL, CMS, FDA
|
NCI, NHLBI, NIA, NIBIB, NINDS, NINR
|
2014
|
|
Interagency Working Group (IWG) on Communicating Hazard Information and Other Types of Uncertainty, White House Office of Science and Technology Policy (OSTP) Subcommittee on Social and Behavioral Sciences (SBS)
|
Committee, Advisory Group, or Work Group
|
FDA
|
OD/ DPCPSI/ OBSSR, NCI, NIMHD, NINR, NCATS
|
|
|
Interagency Working Group in the Glycosciences
|
Committee, Advisory Group, or Work Group
|
FDA
|
NCI, NICHD, NIDCR, NIDDK, NIGMS
|
2008
|
|
Interagency working group on Biological Data Sharing (IWGBDS)
|
Committee, Advisory Group, or Work Group
|
FDA
|
NCI, NIGMS
|
2018
|
|
Interagency Working Group on Harmful Algal Bloom and Hypoxia Research and Control Act (IWG-HABHRCA)
|
Committee, Advisory Group, or Work Group
|
FDA, CDC
|
|
2014
|
|
Interdepartmental Health Equity Collaborative (formerly FIHET)
|
Committee, Advisory Group, or Work Group
|
ACF, ACL, AHRQ, CDC, CMS, FDA, HRSA, IHS, OS, SAMHSA
|
NCATS, NCI, NHLBI, NIA, NIAAA, NIAID, NICHD, NIDA, NIDCR, NIDDK, NIEHS, NIMH, NIMHD, NINR
|
2006
|
|
International Neonatal Consortium
|
Meeting/ Workshop
|
FDA
|
NICHD
|
2015
|
|
International Rare Diseases Research Consortium (IRDiRC) Funders Committee
|
Committee, Advisory Group, or Work Group
|
FDA
|
NCATS, NCI, NEI, NHGRI, NIAMS, NICHD, NINDS
|
2011
|
|
Intragovernmental Select Agents and Toxins Technical Advisory Committee (ISATTAC)
|
Committee, Advisory Group, or Work Group
|
CDC, FDA, OS
|
NCI, NIAID, OD/ ORS, OD/ OSP
|
2005
|
|
Iodine Initiative
|
Resource Development
|
FDA, CDC
|
NICHD, OD/ DPCPSI/ ORWH
|
2011
|
|
|